Dynavax Technologies (DVAX) in Focus: Stock Moves 5.8% Higher

Zacks Equity Research

Dynavax Technologies Corporation ( DVAX) was a big mover last session, as the company saw its shares rise by almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained nearly 31% since Nov 6.

The company has seen three positive revisions and one negative revision over the last 30 days while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for Dynavax Technologies. So make sure to keep an eye on this stock going forward to see if this recent move higher can turn into more strength down the road.

Dynavax Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better performing healthcare stocks include Sucampo Pharmaceuticals, Inc. ( SCMP), Jazz Pharmaceuticals plc ( JAZZ) and Lannett Company, Inc. ( LCI). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




DYNAVAX TECHNOLOGIES CP (DVAX): Free Stock Analysis Report

SUCAMPO PHARMACEUTICALS CL A (SCMP): Free Stock Analysis Report

JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report

LANNETT CO INC (LCI): Free Stock Analysis Report


Zacks Investment Research